Vornorexant

N/A

Report date: 2026/02/04 15:16:07
NME

Base Information

Drug NameVornorexant
Drug Alias NameVornorexant HydrateVorzzzボルズィTS-142ORN-0829
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonistsOrexin receptor type 2 antagonists
TargetsOrexin receptor type 2Orexin receptor type 1
Therapy Area/IndicationsSleep Initiation and Maintenance DisordersSleep Apnea SyndromesHepatic Insufficiency
Global Approved IndicationsSleep Initiation and Maintenance Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2025/08/25
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaisho Pharmaceutical Co Ltd
Inactive CompaniesTaisho Pharmaceutical R&D Inc
Active IndicationsSleep Initiation and Maintenance DisordersSleep Apnea SyndromesHepatic Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A